These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8256503)

  • 1. Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins.
    Charbit A; Martineau P; Ronco J; Leclerc C; Lo-Man R; Michel V; O'Callaghan D; Hofnung M
    Vaccine; 1993 Sep; 11(12):1221-8. PubMed ID: 8256503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of viral B-cell epitopes inserted into two surface loops of the Escherichia coli K12 LamB protein and expressed in an attenuated aroA strain of Salmonella typhimurium.
    Wang J; Michel V; Leclerc C; Hofnung M; Charbit A
    Vaccine; 1999 Jan; 17(1):1-12. PubMed ID: 10078601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and immune response to foreign epitopes in bacteria. Perspectives for live vaccine development.
    Charbit A; Newton SM; Klebba PE; Clément JM; Fayolle C; Lo-Man R; Leclerc C; Hofnung M
    Behring Inst Mitt; 1997 Feb; (98):135-42. PubMed ID: 9382734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics.
    Leclerc C; Charbit A; Martineau P; Deriaud E; Hofnung M
    J Immunol; 1991 Nov; 147(10):3545-52. PubMed ID: 1719080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses.
    Su GF; Brahmbhatt HN; Wehland J; Rohde M; Timmis KN
    Infect Immun; 1992 Aug; 60(8):3345-59. PubMed ID: 1639503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and antigenicity of conserved peptides from the envelope of HIV-1 expressed at the surface of recombinant bacteria.
    Charbit A; Molla A; Ronco J; Clément JM; Favier V; Bahraoui EM; Montagnier L; Leguern A; Hofnung M
    AIDS; 1990 Jun; 4(6):545-51. PubMed ID: 2201318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins.
    Leclerc C; Lo-Man R; Charbit A; Martineau P; Clément JM; Hofnung M
    Int Rev Immunol; 1994; 11(2):123-32. PubMed ID: 7519229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to hybrid maltose-binding proteins.
    O'Callaghan D; Martineau P; Fayolle C; Leclerc C; Guillet JG; Charbit A; Hofnung M
    Vaccine; 1993; 11(2):140-2. PubMed ID: 7679863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein.
    Coëffier E; Clément JM; Cussac V; Khodaei-Boorane N; Jehanno M; Rojas M; Dridi A; Latour M; El Habib R; Barré-Sinoussi F; Hofnung M; Leclerc C
    Vaccine; 2000 Nov; 19(7-8):684-93. PubMed ID: 11115689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope.
    Lo-Man R; Martineau P; Hofnung M; Leclerc C
    Eur J Immunol; 1993 Nov; 23(11):2998-3002. PubMed ID: 8223877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
    Bergmann C; Stohlmann SA; McMillan M
    Eur J Immunol; 1993 Nov; 23(11):2777-81. PubMed ID: 7693478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA
    J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.
    Pincus SH; Messer KG; Schwartz DH; Lewis GK; Graham BS; Blattner WA; Fisher G
    J Clin Invest; 1993 May; 91(5):1987-96. PubMed ID: 7683694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
    Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
    J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a recombinant HIV type 1 glycoprotein 160 boosted by a V3 synthetic peptide in HIV-negative volunteers.
    Salmon-Céron D; Excler JL; Sicard D; Blanche P; Finkielstzjen L; Gluckman JC; Autran B; Matthews TJ; Meignier B; Kieny MP
    AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1479-86. PubMed ID: 8679292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and biological activity of genetic fusions between MalE, the maltose binding protein from Escherichia coli and portions of CD4, the T-cell receptor of the AIDS virus.
    Clément JM; Jehanno M; Popescu O; Saurin W; Hofnung M
    Protein Expr Purif; 1996 Nov; 8(3):319-31. PubMed ID: 8936594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition.
    Lo-Man R; Martineau P; Betton JM; Hofnung M; Leclerc C
    J Immunol; 1994 Jun; 152(12):5660-9. PubMed ID: 7515911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasm. The route of immunization influences the isotypic distribution and the biologic activity of the antipoliovirus antibodies.
    LeClerc C; Martineau P; Van der Werf S; Deriaud E; Duplay P; Hofnung M
    J Immunol; 1990 Apr; 144(8):3174-82. PubMed ID: 2157762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.